SomaLogic, Inc.
SLGC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $462 | $1,597 | $2,506 | $2,506 |
| - Cash | $422 | $439 | $165 | $14 |
| + Debt | $2 | $0 | $37 | $0 |
| Enterprise Value | $42 | $1,157 | $2,378 | $2,492 |
| Revenue | $98 | $82 | $56 | $32 |
| % Growth | 19.7% | 46.1% | 73.6% | – |
| Gross Profit | $54 | $48 | $33 | -$18 |
| % Margin | 55.6% | 59% | 59.5% | -54.5% |
| EBITDA | -$176 | -$86 | -$32 | -$48 |
| % Margin | -180% | -105.4% | -56.4% | -148.5% |
| Net Income | -$109 | -$86 | -$71 | -$57 |
| % Margin | -111.8% | -105.7% | -127.7% | -177.1% |
| EPS Diluted | -0.59 | -0.63 | -0.39 | -0.31 |
| % Growth | 6.3% | -61.5% | -25.8% | – |
| Operating Cash Flow | -$101 | -$37 | -$28 | -$51 |
| Capital Expenditures | -$5 | -$7 | -$1 | -$1 |
| Free Cash Flow | -$106 | -$44 | -$29 | -$51 |